AmeriPath is one of the nation’s leading providers of anatomic pathology and molecular diagnostics. Our team of subspecialized pathologists and Ph.D-level scientists provides an unparalleled level of medical expertise, diagnostic quality and personal consultation services. Moreover, our elite team of more than 400 highly trained, board-certified pathologists provides medical diagnostics services in outpatient laboratories owned, operated and managed by us, as well as in hospitals and ambulatory surgical centers.

Under our ownership or employment model, we acquire a controlling equity (voting) interest or have a controlling financial interest in pathology operations. We refer to these as our owned operations. Under our management or equity model, we acquire certain assets of, and operate pathology laboratories under, long-term management services agreements. Under these agreements, we provide facilities and equipment as well as administrative and technical support for the managed operations.

AmeriPath is a member of the American Clinical Laboratory Association (ACLA), the clinical laboratory industry's leading advocate providing effective communication with Congress, regulatory bodies, other health care organizations and the public. A not-for-profit association, the ACLA represents the nation's leading national and regional clinical laboratories on key issues of common concern, including federal and state government reimbursement and regulatory policies.